Just - Evotec Biologics
Jon Gunther, a highly skilled professional with a Ph.D. in Chemical Engineering, currently serves as Vice President of Business Development at Just - Evotec Biologics since October 2020. Prior to this, Jon held various roles in different companies such as Sana Biotechnology, Juno Therapeutics, Amgen, and Weyerhaeuser, where he showcased his expertise in strategic sourcing, process development, technology strategy, and innovation. Jon's academic background and extensive experience in the biotechnology industry make him a valuable asset in driving business growth and development.
This person is not in the org chart
Just - Evotec Biologics
1 followers
Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com